Chuck Rinker, CEO of PRSONAS, a self-proclaimed Human-AI Innovator, joins the podcast to discuss programming humanity into AI and revolutionizing the clinical trial industry through their iHealthAssist product.  Chuck has gone from developing black-ops military tech and NASA/space-borne avionics through gaming to the creation of nuMedia Innovations and the patented technologies behind it including the Digital Personality Engine that brings human engagement to self-service solutions for...

Today we’re talking to Michael Tarselli Chief Scientific & Knowledge Officer of TetraScience. Mike was the Scientific Director for SLAS, a global professional society dedicated to lab automation and an Associate Director at Novartis building an external scientific collaboration platform. You can read the full bio in the show notes.  TetraScience is bringing the future of scientific data to today and has built the largest integration network of lab instruments, informatics applications,...

Today we’re talking to Mehdi Maghsoodnia, Co-founder of 1Health which is a personalized precision medicine powered by a lab testing platform that connects labs, clinicians and consumers. Listen to get more details about how 1Health is bringing diagnostic to the modern age. We love the mission of 1Health which is to bring advanced diagnostics to market faster and to make them more accessible, affordable and simple. Love that and it’s similar to our mission at Qualio. About Mehdi...

What does a modern lab look like? How much manual data processing will take place? Hopefully very little if Ganymede continues to make an impact. Today Nathan Clark, Co-founder of Ganymede, one of the fastest-growing software startups in biotech joins to talk about how to automate and integrate basically everything in a lab. Before Ganymede Nathan was a product manager at Benchling which is another darling startup in biotech we’ve had our eyes on. You can read his full bio in the show notes...

Dr. Brian Fengler joins us on the show to talk about the latest in healthtech and innovating EHR technology to save lives in fewer clicks. Brian is the Co-Founder and Chief Medical Officer of EvidenceCare (recently named as an Inc. 5000 Fastest-Growing Company), a company that provides a clinical decision support system (CDSS) that’s uniquely integrated with the Electronic Health Record (EHR) to optimize clinician workflows. Dr. Fengler authored a treatment protocol for Pulmonary Embolisms...

We've know many who have or had the job title of "Quality Engineer" however many outside the industry may not consider "quality engineers" to be actual engineers in the traditional sense (like mechanical engineering) - Matt Wictome's children think this way. But Matt explains how quality really is an engineering function because processes, products, and companies are being built or fixed—just as a mechanical engineer may build or fix an airplane. Tune into this episode to learn more about...

We’re going to deviate from our typical life sciences for just a few moments just for fun to talk about dogs. We’ve heard about dogs using their olfactory system to detect biologic changes related to disease. Having a bit of a soft spot for dogs ourselves here at Qualio, when our friend Kayla Fratt reached out to be on the show, we thought it’d be fun to hear about her work in ecology and in the field doing conservation work. Kayla is the founder of K9 Conservationists and Journey Dog...

We're excited to dive into the world of full-service medical outsourcing with Jeff Barrett, President and CEO OF J-Pac Medical. Jeff Barrett has more than 25 years of experience building high-growth medical product-based companies. He leads the advancement of J-Pac’s growth strategy, pursuing opportunities to further drive adoption of the company’s offerings and optimizing capabilities to better serve customers. Prior to joining J-Pac Medical, Barrett held CEO positions at GI Supply and Optim...

Today, we are chatting with Navid Alipour. Navid is the founder and CEO of AI Med Global. Navid believes that with consistent advancements in the healthcare industry, the best care is even more accessible than ever before. When treating cancer, Oncologists are attempting to match the best course of treatment to the individual but every cancer is as unique as the patient! His company, AI Med Global is making curated medicine accessible to cancer patients all over the world. By utilizing...

Today we are chatting with Dr. Brandon McNaughton, CEO and Co-founder of Akadeum Life Sciences. Brandon is an award-winning inventor and scientist with over 15 years of experience working with magnetic beads and nanoparticles. His experience includes the development of new types of particles, separation, and biosensors. Brandon brings previous startup experience in the life sciences and venture capital. He is also a recognized expert in customer discovery and in using human-centered design...

Today, we are excited to chat with Jeff Galvin, CEO of American Gene Technologies®. We are so glad to have Jeff back on the show, we first spoke with him last March to learn about American Gene Technologies and what they were working on. I am excited to hear all the updates and accomplishments since we last chatted. Jeff is the CEO and founder of American Gene Technologies® (AGT). He earned his BA degree in Economics from Harvard and has more than 30 years of business and entrepreneurial...

Today, we are chatting with Ethan Drower, co-founder and operating partner of CiteMed, which is revolutionizing the European Union Medical Device Regulation (EU MDR) process. Literature Search and Review is the cornerstone of medical device companies' Clinical Evaluation Report, and CiteMed has made this process more streamlined and optimized than ever. The CiteMed team was formed to deliver a high volume of beautifully written and formatted Literature Reviews on timelines that will enable...

What does the future of med tech look like? Piotr Zajac of Untitled Kingdom is tackling just that with his team and company. As they say, equality starts with technology.  On today's episode, we chat with Piotr Zajac, CEO of Untitled Kingdom. His company is a known and collaborative partner specializing in software development and product development services. Professionally, Piotr is the President of the Entrepreneurs' Organization and the guardian of Untitled Kingdom's mission to...

Ever wondered about your genes and overall health?  In today's episode, we will talk about just that. with Dr. J Dunn. We go over wholistic kinesiology and wholistic methylation. For over 30 years, she has practiced natural medicine, researched, and taught her groundbreaking techniques to hundreds of individuals who, like her, are on a quest to find an alternative solution to allopathic medicine. Dr. Dunn began her career in the Natural Health Industry after a long bout of ill health, which...

Are you a life sciences start-up founder and want to bring your business to market, but don't know how? Marketing is something that is ever-evolving but should be part of every business' strategy.  In today's episode, you will dive into marketing strategies, testing, industry regulations, and more in the healthcare sector with Jason and Scott from Webtek Interactive. Webtek Interactive is a full-service marketing agency that works with enterprise clients. They specialize in digital strategy...

We all experienced the importance of at-home testing from the Covid19 pandemic and today's guest is helping bring rapid, affordable, and accurate tests to everyone including traditionally underserved areas.  Dive into how Domus Diagnostics got started, the importance of Nucleic Acid Testing, and getting started with clinical trials to get FDA clearance with Kelly and Paul on this episode of From Lab to Launch. About Paul Chapman From sales representative to CEO, Board Member and Angel...

Today on the show we're joined by Shuo Qiao, Co-founder and Chief Technology Officer of Moving Analytics. We discuss his career path and how it earned him a spot on the Forbes 30 Under 30 list, his interest in computer science, and crossing paths with his future business partner. Dive into funding strategies, the rise and global impact of telehealth, and the future of digital health tech on this episode of From Lab to Launch. About Shuo Qiao Shuo Qiao is the Co-founder and Chief Technology...

Can a chemical found in citrus fruit curb cancer and save lives through early detection? Today on the show, we'll talk about the possibilities with Dr. David Suhy, Cofounder and Chief Medical Officer of Earli. Earli was founded with the mission to make cancer a benign experience by catching and curing it early. According the the American Cancer Society, 40% of people will be diagnosed with cancer at some point in their lifetime. And a third will die from it. What if there was a way to...

Today we’re catching up with Dr. Heather Underwood, CEO of EvoEndo. EvoEndo recently completed an $8.4 million Series A financing round on the heels of 510(k) FDA clearance in early 2022. We first spoke with Dr. Underwood in June of 2021. In this episode, we chart a course through her accomplishments, lessons learned through the FDA clearance process, working with CROs, and hear firsthand about the challenges she’s tackled as Chief Executive of a medical device startup ready to revolutionize...

Today we speak with developer turned health-tech founder Gulé Sheikh. We discuss her innovations and entrepreneurship at a leading tele-health company, her experience in technology, and the importance of representation.  In the early 20th century, women led computer programming and made huge contributions to the field. From Ada Lovelace’s algorithm and Grace Hopper’s pioneering work on COBOL to World War II codebreaking at Bletchley Park and Katherine Johnson’s calculations critical to NASA...

Non-invasive ventilation (NIV) is a life-saving tool used throughout ICUs to manage respiratory failure. The traditional form of non-invasive ventilation, a tight-fitting mask placed over a patient's nose and mouth, comes with significant drawbacks. What if there was an option to treat patients with respiratory failure that improved outcomes while reducing the likelihood for invasive intubation?  Today on the show, we speak with Aurika Savickaite about an FDA-approved alternative—helmet-based...

The average cost of developing a new drug is estimated at over $2 billion. Roughly 10% of pre-clinical drugs ever make it to human trials. And each year, $50 billion is “misspent” in the trial & error method of research and development. An AI-enabled “decision engine” could help researchers find cures to rare diseases, bridge the translational gap between animal models to human systems, and move faster in drug development reducing associated R&D costs.  Today on the show we chat with...

What if you started a company like Roche (est. in 1896) from the ground up? How would you approach drug development differently given enabling technology available today? That's the question Diego Rey and the other founders of Endpoint Health asked.  Diego Rey is a co-founder and Chief Scientific Office of Endpoint Health, which is flipping the traditional drug development model on its head with a precision-medicine approach. In the past, biopharma companies would start with a molecule and...

What’s the background of a Noble Prize winner in chemistry, where are the next innovations in science, and how do you say “asymmetric organocatalysis”? Find out the answers on this week's episode as we chat with David MacMillan.  From food production to industrial manufacturing, catalysts are all around us and play an outsized role in our lives. It’s estimated that 90% of all commercially produced chemical products are reliant on catalysts at some point in the manufacturing process. Many of...

Today, we have Lyn Yaffe joining us. Lyn is the Co-founder, Chairman, and CEO of EPR-Technologies. EPR Technologies is a biomedical spinoff of the Safar Center for Resuscitation Research, University of Pittsburgh. EPR Technologies is committed to the preservation of human life through rapid profound hypothermia, by pursuing techniques and patented products for emergency preservation and resuscitation (EPR) to save a life when standard cardiopulmonary resuscitation (CPR) fails.  In the past...